Lincoln Pharmaceuticals has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2017, to consider the approval and adoption of Audited Consolidated and Standalone Financial results of the Company for the Quarter and Year ended on March 31, 2017, Recommendation of dividend on Equity Shares of the Company for the Financial Year ended on March 31, 2017, if any. In view of above, the trading window will remain close for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from May 20, 2017 and shall reopen after the expiry of 48 hours from the time the result becomes generally available.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: